NCT00754507View on ClinicalTrials.gov

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

April 30, 2005

Conditions
Hypercholesterolemia
Interventions
DRUG

colesevelam HCl tablets, and atorvastatin tablets

colesevelam HCl tablets,6 tablets/day; atorvastatin tablets, 1 tablets/day for 6 weeks

DRUG

colesevelam HCl placebo tablets and atorvastatin tablets

colesevelam HCl placebo tablets, 6 tablets/day for 6 weeks atorvastatin tablets, 1 tablet/day for 6 weeks

Trial Locations (13)

Unknown

Los Angeles

Castle Rock

Jacksonville

Pembroke Pines

St. Petersburg

Indianapolis

Rochester

Cincinnati

Cleveland

Bartlett

Norfolk

Richmond

Seattle

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00754507 - A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks. | Biotech Hunter | Biotech Hunter